Lapatinib: A small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor-2 tyrosine kinases used in the treatment of breast cancer

Amye J. Tevaarwerk, Jill M. Kolesar

Research output: Contribution to journal › Article › peer-review

103 Scopus citations

Fingerprint

Dive into the research topics of 'Lapatinib: A small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor-2 tyrosine kinases used in the treatment of breast cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science